ArticleBMC medical genomics2018

Patient with multiple acyl-CoA dehydrogenase deficiency disease and ETFDH mutations benefits from riboflavin therapy: a case report.

Liuh Ling Goh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.